NPI: 1235183542 · WARRENSVILLE HEIGHTS, OH 44122 · General Acute Care Hospital · NPI assigned 05/20/2006
Authorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
| Authorized Official | LARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER) |
| NPI Enumeration Date | 05/20/2006 |
Other providers sharing the same authorized official: LARAWAY, DENNIS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 80,579 | $2.47M |
| 2019 | 69,875 | $2.31M |
| 2020 | 49,292 | $2.91M |
| 2021 | 63,452 | $3.68M |
| 2022 | 71,739 | $3.21M |
| 2023 | 238,911 | $10.11M |
| 2024 | 192,046 | $6.73M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 36,476 | 34,054 | $4.86M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 33,781 | 30,977 | $4.85M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 31,105 | 27,112 | $4.78M |
| 96361 | Intravenous infusion, hydration; each additional hour | 10,292 | 6,977 | $3.42M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 24,501 | 18,914 | $2.08M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 8,436 | 7,168 | $1.19M |
| 70450 | Computed tomography, head or brain; without contrast material | 3,233 | 2,665 | $974K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4,350 | 3,924 | $722K |
| G0378 | Hospital observation service, per hour | 10,705 | 4,589 | $685K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,142 | 1,757 | $602K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,828 | 3,508 | $507K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,692 | 2,024 | $462K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,747 | 931 | $415K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,559 | 1,897 | $341K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,421 | 1,142 | $298K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,078 | 895 | $296K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 624 | 490 | $291K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3,950 | 1,926 | $264K |
| 80053 | Comprehensive metabolic panel | 40,227 | 31,814 | $263K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,932 | 981 | $203K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,995 | 3,832 | $189K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 630 | 524 | $178K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 303 | 232 | $157K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 463 | 392 | $134K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 863 | 418 | $125K |
| 93970 | 658 | 538 | $91K | |
| 11045 | 156 | 71 | $86K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 7,218 | 4,671 | $72K |
| 71250 | 652 | 587 | $69K | |
| 97161 | 1,851 | 1,518 | $68K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 492 | 469 | $68K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 648 | 555 | $66K |
| 93971 | 651 | 547 | $64K | |
| 81513 | 388 | 357 | $63K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4,434 | 3,553 | $62K |
| 82805 | 1,480 | 1,102 | $58K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 158 | 140 | $57K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 231 | 211 | $54K |
| 84484 | 15,933 | 10,221 | $51K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 41,902 | 33,700 | $51K |
| 93976 | 358 | 304 | $51K | |
| 36415 | Collection of venous blood by venipuncture | 68,296 | 44,103 | $51K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 24,339 | 19,888 | $50K |
| 76830 | Ultrasound, transvaginal | 760 | 659 | $48K |
| 71046 | Radiologic examination, chest; 2 views | 3,792 | 3,297 | $47K |
| 97165 | 871 | 685 | $46K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6,488 | 5,936 | $46K |
| 80069 | 4,754 | 2,279 | $44K | |
| 85027 | 12,343 | 7,293 | $43K | |
| 76770 | 265 | 240 | $40K | |
| 87631 | 202 | 195 | $39K | |
| 93799 | 6,751 | 2,275 | $39K | |
| 97113 | 537 | 238 | $38K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,875 | 2,380 | $38K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 56 | 53 | $35K |
| 70498 | 85 | 69 | $35K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,141 | 580 | $33K |
| 80061 | Lipid panel | 2,495 | 2,171 | $31K |
| 71045 | Radiologic examination, chest; single view | 11,161 | 9,481 | $30K |
| 43235 | 66 | 53 | $30K | |
| 83735 | 18,114 | 11,689 | $30K | |
| 86850 | 1,164 | 906 | $30K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 48 | 44 | $29K |
| 96367 | 707 | 478 | $29K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 15,768 | 9,637 | $28K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 15,534 | 13,171 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,321 | 1,905 | $27K |
| 97535 | Self-care/home management training, each 15 minutes | 960 | 606 | $26K |
| 74018 | 715 | 549 | $26K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,150 | 1,007 | $25K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,002 | 917 | $25K |
| 12001 | 118 | 94 | $24K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 257 | 231 | $24K |
| 97802 | 401 | 331 | $24K | |
| 73630 | 1,111 | 954 | $23K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6,504 | 5,951 | $23K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 559 | 289 | $21K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 56 | 48 | $21K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 537 | 479 | $21K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,308 | 1,113 | $21K |
| 97116 | 720 | 428 | $20K | |
| 82962 | 13,523 | 3,974 | $20K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 926 | 845 | $19K |
| 73564 | 622 | 531 | $18K | |
| 86780 | 2,682 | 2,348 | $18K | |
| 99253 | 495 | 447 | $18K | |
| 70491 | 41 | 31 | $18K | |
| 70486 | 429 | 382 | $18K | |
| 73030 | 925 | 771 | $17K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 118 | 107 | $17K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 797 | 541 | $17K |
| 10060 | 79 | 64 | $16K | |
| 86900 | 1,189 | 913 | $16K | |
| 96127 | 468 | 329 | $16K | |
| 11043 | 96 | 49 | $16K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 731 | 627 | $15K |
| 81001 | 29,110 | 26,039 | $15K | |
| 82728 | 1,042 | 888 | $14K | |
| 73610 | 959 | 758 | $14K | |
| 86803 | 620 | 540 | $14K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | 13 | $13K |
| 72100 | 575 | 511 | $13K | |
| 85610 | 11,573 | 7,107 | $13K | |
| 90715 | 738 | 544 | $13K | |
| 84702 | 1,025 | 755 | $13K | |
| 73130 | 888 | 751 | $12K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,223 | 1,152 | $12K |
| J1756 | Injection, iron sucrose, 1 mg | 369 | 134 | $11K |
| 82607 | 643 | 563 | $11K | |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | 42 | 13 | $11K |
| 73560 | 799 | 690 | $11K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 1,262 | 836 | $10K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 86 | 79 | $10K |
| 86140 | 1,260 | 1,017 | $10K | |
| 83880 | 1,921 | 1,550 | $10K | |
| 72197 | 31 | 26 | $10K | |
| 99152 | 366 | 314 | $10K | |
| 83540 | 1,119 | 955 | $10K | |
| 84439 | 597 | 471 | $9K | |
| 70496 | 145 | 112 | $9K | |
| 73502 | 658 | 526 | $9K | |
| 87340 | 562 | 453 | $9K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 526 | 487 | $8K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3,035 | 2,624 | $8K |
| 76801 | 354 | 295 | $8K | |
| A9270 | Non-covered item or service | 3,111 | 1,251 | $8K |
| 73110 | 572 | 482 | $8K | |
| 82570 | 661 | 592 | $8K | |
| 83550 | 1,105 | 947 | $8K | |
| 74183 | 27 | 24 | $7K | |
| 93017 | 104 | 92 | $7K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 301 | 166 | $7K |
| 43245 | 15 | 13 | $6K | |
| 99221 | 555 | 504 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,610 | 3,785 | $6K |
| 86901 | 1,189 | 913 | $6K | |
| 96376 | 3,195 | 1,455 | $6K | |
| 82550 | 2,591 | 1,727 | $6K | |
| 99232 | Subsequent hospital care, per day, moderate complexity | 457 | 396 | $5K |
| 80076 | 630 | 531 | $5K | |
| 83970 | 166 | 138 | $5K | |
| 98927 | 181 | 163 | $5K | |
| 96368 | 154 | 102 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,974 | 1,726 | $5K |
| 76857 | 368 | 301 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 284 | 243 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3,130 | 2,757 | $4K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 73 | 71 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,945 | 1,608 | $4K |
| 93321 | 17 | 12 | $4K | |
| 84100 | 1,114 | 695 | $4K | |
| 76536 | 21 | 21 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 864 | 619 | $4K |
| 84153 | 232 | 206 | $4K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 34 | 25 | $4K |
| 83690 | 5,997 | 4,946 | $4K | |
| 82077 | 2,487 | 1,865 | $4K | |
| 82043 | 438 | 399 | $3K | |
| 12011 | 16 | 13 | $3K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 13 | 12 | $3K |
| 86706 | 215 | 163 | $3K | |
| 98928 | 96 | 89 | $3K | |
| 81025 | 19,825 | 17,976 | $3K | |
| 82553 | 1,425 | 839 | $3K | |
| 94760 | 3,389 | 1,726 | $2K | |
| 83605 | 2,127 | 1,401 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 477 | 367 | $2K |
| 73590 | 223 | 181 | $2K | |
| 87077 | 966 | 802 | $2K | |
| 85652 | 332 | 273 | $2K | |
| 99153 | Mod sedat endo service >5yrs | 274 | 227 | $2K |
| 99215 | Prolong outpt/office vis | 52 | 49 | $2K |
| 86703 | 1,997 | 1,758 | $2K | |
| 93356 | 110 | 92 | $2K | |
| 76642 | 14 | 12 | $2K | |
| 85379 | 1,205 | 977 | $2K | |
| 82330 | 1,656 | 1,145 | $2K | |
| 98926 | 57 | 55 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | 6,940 | 2,278 | $2K |
| 82746 | 264 | 227 | $2K | |
| 87040 | 614 | 427 | $2K | |
| 92610 | 30 | 25 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,154 | 3,374 | $1K |
| 84550 | 285 | 240 | $1K | |
| 85730 | 1,607 | 1,126 | $1K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 506 | 258 | $1K |
| 82784 | 68 | 56 | $1K | |
| 86480 | 16 | 12 | $1K | |
| 85018 | 1,636 | 1,200 | $964.91 | |
| 82248 | 301 | 239 | $949.48 | |
| 80143 | 304 | 227 | $909.52 | |
| 87186 | 721 | 613 | $909.40 | |
| 73140 | 72 | 60 | $852.03 | |
| 84132 | 1,725 | 1,296 | $829.95 | |
| 92526 | 22 | 12 | $779.62 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,411 | 1,162 | $749.25 |
| 87205 | 706 | 576 | $749.05 | |
| 83615 | 112 | 85 | $740.38 | |
| 97162 | 13 | 12 | $736.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 12,597 | 10,705 | $725.46 |
| 87522 | Neg quan hep c or qual rna | 16 | 13 | $715.05 |
| 82375 | 1,504 | 1,123 | $691.33 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,550 | 932 | $669.08 |
| 00731 | 751 | 622 | $668.64 | |
| 90686 | 83 | 77 | $666.44 | |
| J1815 | Injection, insulin, per 5 units | 162 | 112 | $663.11 |
| 87481 | 309 | 291 | $633.75 | |
| 87070 | 349 | 261 | $631.12 | |
| C9113 | Injection, pantoprazole sodium, per vial | 421 | 211 | $622.40 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 774 | 659 | $603.97 |
| 90656 | 43 | 39 | $580.08 | |
| 84156 | 95 | 83 | $562.26 | |
| 83721 | 70 | 68 | $545.00 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 19 | 19 | $523.60 |
| 80179 | 274 | 203 | $507.16 | |
| 83050 | 1,514 | 1,119 | $460.73 | |
| 82435 | 1,388 | 1,046 | $455.00 | |
| 84403 | 19 | 16 | $450.70 | |
| 73080 | 41 | 38 | $422.47 | |
| 73090 | 14 | 12 | $417.35 | |
| 87808 | 809 | 765 | $413.47 | |
| 86038 | 25 | 24 | $409.69 | |
| Q3014 | Telehealth originating site facility fee | 14 | 14 | $389.58 |
| 80074 | 17 | 12 | $332.75 | |
| 94799 | 17 | 12 | $326.17 | |
| 80320 | 209 | 196 | $297.43 | |
| 82010 | 388 | 286 | $284.77 | |
| 84295 | 1,470 | 1,104 | $270.16 | |
| 85045 | 137 | 122 | $263.42 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 452 | 294 | $259.59 |
| J1170 | Injection, hydromorphone, up to 4 mg | 584 | 318 | $250.57 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 842 | 554 | $243.41 |
| 83520 | 13 | 13 | $223.39 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,169 | 783 | $213.89 |
| J2704 | Injection, propofol, 10 mg | 5,523 | 2,894 | $182.01 |
| J3490 | Unclassified drugs | 40 | 25 | $169.09 |
| 83695 | 57 | 53 | $156.04 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 3,688 | 2,513 | $154.92 |
| 87430 | 402 | 367 | $150.65 | |
| 73552 | 37 | 32 | $135.05 | |
| 84165 | 13 | 12 | $114.76 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 253 | 169 | $105.14 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 128 | 51 | $103.60 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,639 | 1,056 | $100.51 |
| J2060 | Injection, lorazepam, 2 mg | 552 | 351 | $94.13 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 5,378 | 3,790 | $91.19 |
| 81003 | 317 | 276 | $84.46 | |
| 84703 | 78 | 70 | $82.46 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,613 | 2,050 | $77.81 |
| 80164 | 28 | 25 | $72.71 | |
| 84155 | 16 | 13 | $68.65 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 1,740 | 949 | $65.07 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 159 | 149 | $58.78 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 27 | 27 | $58.01 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 905 | 616 | $57.28 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 147 | 82 | $49.92 |
| J1790 | Injection, droperidol, up to 5 mg | 439 | 331 | $48.56 |
| 88342 | 40 | 28 | $48.31 | |
| J3480 | Injection, potassium chloride, per 2 meq | 295 | 199 | $47.44 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,878 | 1,358 | $47.40 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 37 | 28 | $44.30 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,961 | 1,325 | $41.62 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 250 | 186 | $31.88 |
| 84145 | 36 | 31 | $28.65 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 35 | 16 | $25.28 |
| J0690 | Injection, cefazolin sodium, 500 mg | 950 | 641 | $13.92 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 41 | 40 | $13.82 |
| 71101 | 50 | 36 | $11.75 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 464 | 382 | $11.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 47 | 34 | $9.19 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 174 | 147 | $6.75 |
| J3370 | Injection, vancomycin hcl, 500 mg | 66 | 38 | $5.16 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 58 | 28 | $3.04 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 149 | 133 | $2.18 |
| 99233 | Prolong inpt eval add15 m | 30 | 27 | $0.00 |
| 00811 | 262 | 203 | $0.00 | |
| 87660 | 26 | 25 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 158 | 127 | $0.00 |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 24 | 24 | $0.00 |
| 3078F | 146 | 130 | $0.00 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 48 | 44 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 32 | 32 | $0.00 |
| 87899 | 27 | 26 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 27 | 18 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 116 | 90 | $0.00 |
| 87480 | 26 | 25 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 134 | 100 | $0.00 |
| 74174 | 14 | 12 | $0.00 | |
| 3074F | 181 | 165 | $0.00 | |
| C1726 | Catheter, balloon dilatation, non-vascular | 15 | 13 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 18 | 16 | $0.00 |
| C1769 | Guide wire | 292 | 228 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 20 | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 80 | 77 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 92 | 51 | $0.00 |
| 00813 | 78 | 56 | $0.00 | |
| 3079F | 41 | 40 | $0.00 | |
| 87510 | 26 | 25 | $0.00 | |
| 00952 | 18 | 13 | $0.00 |